Generic Cancer Drug MDL Tossed In Light Of Mensing

Law360, New York (January 31, 2012, 5:22 PM EST) -- A New York federal judge on Monday tossed multidistrict litigation accusing Hospira Inc., Sandoz Inc. and three others of failing to warn consumers about the risks associated with generic versions of cancer treatment Aredia, citing the U.S. Supreme Court's decision in Pliva Inc. v. Mensing.

U.S. District Judge Kiyo A. Matsumoto found that the remaining nine plaintiffs' state-law tort claims, which stemmed from the patients' development of osteonecrosis of the jaw after taking pamidronate, were preempted by federal regulations applicable to generic drugs.

In granting the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.